21st Jul 2020 19:01
Renalytix AI PLC - Cardiff, Wales-based clinical diagnostics company - Raises USD74.3 million in global offering of 5.5 million American depositary shares at USD13.50 each. Company on Friday said USD25 million to USD30 million will be used for the continued development and commercialisation of its KidneyIntelX platform, while the remainder goes to working capital and other corporate purposes.
Current stock price: 531.00 pence
Year-to-date change: up 46%
By Eric Cunha; [email protected]
Copyright 2020 Alliance News Limited. All Rights Reserved.
Related Shares:
Renalytix Plc